PIERONI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.635
EU - Europa 1.213
AS - Asia 847
AF - Africa 33
SA - Sud America 29
OC - Oceania 2
Totale 3.759
Nazione #
US - Stati Uniti d'America 1.620
CN - Cina 418
IT - Italia 309
IE - Irlanda 293
SG - Singapore 272
SE - Svezia 225
FI - Finlandia 121
TR - Turchia 98
DE - Germania 86
AT - Austria 43
BR - Brasile 28
CI - Costa d'Avorio 28
GB - Regno Unito 24
CZ - Repubblica Ceca 19
FR - Francia 19
BE - Belgio 18
IN - India 16
NL - Olanda 15
KR - Corea 12
CA - Canada 10
LU - Lussemburgo 9
ES - Italia 7
HK - Hong Kong 7
LT - Lituania 5
PK - Pakistan 5
UA - Ucraina 4
ID - Indonesia 3
PA - Panama 3
TW - Taiwan 3
VN - Vietnam 3
AU - Australia 2
CH - Svizzera 2
EG - Egitto 2
GH - Ghana 2
IQ - Iraq 2
MY - Malesia 2
NO - Norvegia 2
PL - Polonia 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
CY - Cipro 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JP - Giappone 1
ME - Montenegro 1
MX - Messico 1
NP - Nepal 1
PT - Portogallo 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 3.759
Città #
Chandler 339
Dublin 291
Singapore 202
Santa Clara 191
Ann Arbor 146
Ashburn 99
Parma 91
Boardman 78
Dearborn 72
Izmir 72
Shanghai 70
Nanjing 61
Beijing 57
Princeton 57
Helsinki 54
Wilmington 43
Bremen 40
Vienna 35
Abidjan 28
Chicago 26
Kocaeli 21
New York 20
Guangzhou 19
San Mateo 18
Hefei 17
Nanchang 17
Shenyang 17
Falls Church 16
Hebei 16
Brussels 15
Milan 15
Changsha 14
Jinan 13
Seattle 13
Brno 12
Jiaxing 12
Los Angeles 12
Norwalk 12
Bologna 11
Houston 9
Dallas 8
Des Moines 8
Fremont 8
Munich 8
Florence 7
London 7
Dalmine 6
Sassari 6
Woodbridge 6
Birmingham 5
Fairfield 5
Hong Kong 5
Istanbul 5
Luxembourg 5
Modena 5
New Brunswick 5
Ningbo 5
Brescia 4
Chongqing 4
Dordrecht 4
Frankfurt am Main 4
Haikou 4
Kunming 4
Pune 4
San Giuliano Milanese 4
Verona 4
Washington 4
Zhengzhou 4
Ahmedabad 3
Amstelveen 3
Bandung 3
Beitou 3
Edinburgh 3
Gonzaga 3
Grafing 3
Gwanak-gu 3
Kyiv 3
Lucca 3
Ottawa 3
Panama City 3
Reggio Emilia 3
Rockville 3
Rome 3
Sissa 3
São Paulo 3
Uppsala 3
Ancona 2
Angers 2
Antwerpen 2
Baghdad 2
Basel 2
Brasília 2
Brisbane 2
Cairo 2
Carpi 2
Chengdu 2
Chiniot 2
Daejeon 2
Dong Ket 2
Dudelange 2
Totale 2.581
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 151
Nuovi composti antimicrobici 146
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 122
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 117
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 95
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 94
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 91
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 87
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 85
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 83
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 83
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 81
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 80
Antituberculosis agents: Beyond medicinal chemistry rules 80
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 79
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 77
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 76
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 75
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 73
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 72
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 68
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 67
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 66
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 65
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 65
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 65
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 64
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 62
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 61
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 60
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 60
Towards the sustainable discovery and development of new antibiotics 57
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 55
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 52
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 52
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 52
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 52
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 52
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 51
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 51
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 48
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 48
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 45
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 44
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 43
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 42
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 40
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 40
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 40
Indoleamides are active against drug-resistant mycobacterium tuberculosis 35
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 33
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 33
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 33
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 33
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 33
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 31
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 31
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 30
Spectinamides: A challenge, a proof, and a suggestion 30
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 30
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 29
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 29
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 28
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 26
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 25
Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes 9
Totale 3.912
Categoria #
all - tutte 18.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020229 0 0 0 0 0 74 47 8 27 49 17 7
2020/2021201 3 5 8 10 6 12 8 24 46 41 17 21
2021/2022379 15 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/2025753 64 90 144 95 151 209 0 0 0 0 0 0
Totale 3.912